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Background: Musculoskeletal Ultrasound (US) is increasingly used as a valid and reliable tool 
for diagnosis and management of inflammatory arthritis. However, its use in Systemic Lupus 
Erythematosus (SLE) and Sjogren’s syndrome (SS) patients in clinical practice remains less 
established. 
Objectives: To analyse a real life cohort of SLE and SS patients referred for US assessment of 
their hand joints in the context of clinical symptoms of arthralgia/arthritis, to review their 
characteristics and correlate US findings with clinical and laboratory markers, and disease 
activity scores (musculoskeletal ESSDAI and BILAG).  
Methods: We performed a cross-sectional study of patients with SLE and SS referred to 
our US clinic in the last year.  The OMERACT US scoring system was used to assess patients’ 
wrists, metacarpophalangeal and proximal interphalangeal joints bilaterally.  
Results: Patient characteristics and differences between ultrasound findings in SLE (n=18) and 
SS (n=23) patients are shown in Figure 1. There was no correlation between the total PD score 
and musculoskeletal BILAG and ESSDAI scores (R=0.36, P= 0.12, and R=0.32, P=0.13, 
respectively). Similarly, there was no correlation between the total Grey Scale score (assessing 
the degree of synovial hypertrophy) with either BILAG or ESSDAI scores (R=0.41, P=0.09, 
and R=0.084, P=0.7, respectively). Interestingly, more than one in two SLE patients had 
erosions, while more than one in three had erosions in the SS group (Table 1). In addition, the 
US assessment prompted treatment changes (including both optimisation of 
immunosuppressive therapy or analgesia based on the results of the scan) in up to 61% of SLE 
patients and in 35% of SS patients, who would have otherwise not had their treatment changed 
based on BILAG/ESSDAI scores alone. 
Conclusion: US examination was proven superior to clinical examination and blood test results 
for optimising the management of hand arthralgia/arthritis associated with SLE and SS. Our 
study showed that active joint inflammation was found in 27.8% of SLE patients while twice 
as many already had erosions. Future research is needed to establish if the development of 
erosions could be prevented by early diagnosis and prompt treatment of inflammatory arthritis 
associated with SLE and SS.  
 
 
 
 
 
